Total Payments
$537.94
2024 Payments
$22.76
Companies
13
Transactions
32
Medicare Patients
1,816
Medicare Billing
$188,772
Payment Breakdown by Category
Food & Beverage$537.94 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $537.94 | 32 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $101.37 | 7 | $0 (2021) |
| Amgen Inc. | $100.63 | 5 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $76.12 | 3 | $0 (2019) |
| Allergan Inc. | $50.52 | 4 | $0 (2017) |
| Lilly USA, LLC | $50.41 | 4 | $0 (2019) |
| Novo Nordisk Inc | $41.63 | 2 | $0 (2019) |
| ABBVIE INC. | $24.71 | 1 | $0 (2023) |
| Grifols USA, LLC | $22.76 | 1 | $0 (2024) |
| Amarin Pharma Inc. | $19.67 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $15.32 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22.76 | 1 | Grifols USA, LLC ($22.76) |
| 2023 | $24.71 | 1 | ABBVIE INC. ($24.71) |
| 2021 | $16.46 | 1 | AstraZeneca Pharmaceuticals LP ($16.46) |
| 2020 | $15.32 | 1 | E.R. Squibb & Sons, L.L.C. ($15.32) |
| 2019 | $130.55 | 6 | Merck Sharp & Dohme Corporation ($49.68) |
| 2018 | $222.49 | 14 | AstraZeneca Pharmaceuticals LP ($73.08) |
| 2017 | $105.65 | 8 | Allergan Inc. ($50.52) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Pulmonology | ||||||
| 03/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/15/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.32 | General |
| Category: Cardiovascular | ||||||
| 12/12/2019 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $49.68 | General |
| Category: WOMENS HEALTH | ||||||
| 12/05/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Hypertriglyceridemia | ||||||
| 11/22/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Diabetes | ||||||
| 10/02/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Respiratory | ||||||
| 09/04/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Bone Health | ||||||
| 01/09/2019 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: Diabetes | ||||||
| 11/14/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Neuroscience | ||||||
| 11/07/2018 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Diabetes | ||||||
| 10/24/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: Diabetes | ||||||
| 10/03/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Respiratory | ||||||
| 09/19/2018 | Lilly USA, LLC | BASAGLAR (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: Diabetes | ||||||
| 09/18/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Endocrinology | ||||||
| 08/30/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/11/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: Respiratory | ||||||
| 06/06/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $10.96 | General |
| Category: Central Nervous System (CNS) | ||||||
| 05/02/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Respiratory | ||||||
| 04/25/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/24/2018 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: Diabetes | ||||||
| 04/04/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Endocrinology | ||||||
| 02/14/2018 | AstraZeneca Pharmaceuticals LP | DALIRESP (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Respiratory | ||||||
| 11/07/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 355 | 541 | $117,062 | $39,141 |
| 2022 | 8 | 441 | 763 | $169,545 | $52,240 |
| 2021 | 9 | 483 | 756 | $182,880 | $56,223 |
| 2020 | 12 | 537 | 783 | $129,794 | $41,168 |
Total Patients
1,816
Total Services
2,843
Medicare Billing
$188,772
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 116 | 284 | $50,552 | $16,990 | 33.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 120 | 121 | $19,892 | $7,551 | 38.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 63 | 66 | $22,067 | $6,669 | 30.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 36 | $16,151 | $4,763 | 29.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 21 | 34 | $8,400 | $3,169 | 37.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 141 | 368 | $65,318 | $20,131 | 30.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 60 | 151 | $38,807 | $12,045 | 31.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 117 | 120 | $21,480 | $6,637 | 30.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 32 | 32 | $15,968 | $4,829 | 30.2% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 30 | 30 | $13,262 | $4,024 | 30.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 38 | 39 | $6,981 | $2,177 | 31.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $4,044 | $1,261 | 31.2% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $3,685 | $1,135 | 30.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 82 | 206 | $52,832 | $16,746 | 31.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 111 | 248 | $44,144 | $13,816 | 31.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 52 | 53 | $26,188 | $8,387 | 32.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 108 | 111 | $19,869 | $6,226 | 31.3% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 39 | 40 | $18,081 | $5,753 | 31.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 33 | 33 | $5,721 | $1,768 | 30.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 11 | 11 | $3,124 | $1,442 | 46.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 34 | 40 | $10,520 | $1,353 | 12.9% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 13 | 14 | $2,401 | $731.74 | 30.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 153 | 297 | $77,801 | $21,328 | 27.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 95 | 123 | $21,903 | $6,413 | 29.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 45 | 45 | $12,780 | $5,160 | 40.4% |
About Dr. Robert Orr, DO
Dr. Robert Orr, DO is a Family Medicine healthcare provider based in Troy, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2013. The National Provider Identifier (NPI) number assigned to this provider is 1821436379.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Orr, DO has received a total of $537.94 in payments from pharmaceutical and medical device companies, with $22.76 received in 2024. These payments were reported across 32 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($537.94).
As a Medicare-enrolled provider, Orr has provided services to 1,816 Medicare beneficiaries, totaling 2,843 services with total Medicare billing of $188,772. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Troy, PA
- Active Since 06/06/2013
- Last Updated 02/10/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1821436379
Products in Payments
- Prolia (Biological) $59.43
- SYMBICORT (Drug) $52.68
- NEXPLANON (Drug) $49.68
- Ozempic (Drug) $41.63
- FARXIGA (Drug) $35.30
- LINZESS (Drug) $28.80
- JANUVIA (Drug) $26.44
- TRULICITY (Drug) $25.86
- VRAYLAR (Drug) $24.71
- Prolastin-C Liquid (Biological) $22.76
- NAMZARIC (Drug) $21.72
- EVENITY (Biological) $21.62
- Vascepa (Drug) $19.67
- Aimovig (Biological) $19.58
- ELIQUIS (Drug) $15.32
- DALIRESP (Drug) $13.39
- BASAGLAR (Drug) $12.76
- CHANTIX (Drug) $12.55
- JARDIANCE (Drug) $11.79
- LATUDA (Drug) $11.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Troy
Dr. Todd Pearlstein, M.d,, M.D,
Family Medicine — Payments: $15,526
Family Medicine $15,526
Eric Law, Md, MD
Family Medicine — Payments: $15,209
Family Medicine $15,209
Dr. Neil Jaddou, M.d, M.D
Family Medicine — Payments: $14,544
Family Medicine $14,544
John Woodyear,Jr, Md, MD
Family Medicine — Payments: $13,977
Family Medicine $13,977
Dr. Jacquelyn Mclean Bennett, Do, DO
Family Medicine — Payments: $13,113
Family Medicine $13,113
Dr. Adetutu Adetona, M.d, M.D
Family Medicine — Payments: $11,339
Family Medicine $11,339